Adaptive Biotechnologies debuts T-cell Lyme disease test

2019 04 19 20 00 0990 Borrelia Burgdorferi Lyme 400

Adaptive Biotechnologies has launched a test that identifies T cells activated by Borrelia burgdorferi, the bacterium that causes Lyme disease.

T-Detect Lyme, a blood test that aims to diagnose Lyme disease sooner, uses Adaptive's sequencing capabilities and Microsoft's cloud-scale AI (artificial intelligence) to characterize the T-cell repertoire and identify a clinical signal for disease.

T-Detect detects an immune response by leveraging the body's unique T-cell response to disease-associated antigens.

The test is available to patients with a prescription through a qualified healthcare professional.

Page 1 of 1